Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1988 Nov;133(2):211–217.

Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.

G S Pinkus 1, J W Said 1
PMCID: PMC1880773  PMID: 3263805

Abstract

Immunoreactivity for L26, a highly effective pan B cell marker that can be detected in paraffin sections, was evaluated in 72 cases of Hodgkin's disease of various histologic types. In all cases of nodular lymphocyte predominance type of Hodgkin's disease, L & H variants of Reed-Sternberg cells uniformly exhibited strong immunoreactivity for L26. Other variants of Reed-Sternberg cells, eg, lacunar, mononuclear, and diagnostic forms, present in nodular sclerosis, mixed cellularity, and lymphocyte depletion types of Hodgkin's disease, infrequently expressed L26 reactivity. In 55 of 63 cases (87%) of these combined types, less than 5% of Reed-Sternberg cells or variants were L26 positive. In the remaining cases, a larger proportion of these cells expressed L26. Topographic patterns of immunoreactivity for small lymphocytes in these different types of Hodgkin's disease also varied. In nodular lymphocyte predominance type, L26 positive lymphocytes (presumptive B cells) were mainly localized to nodular areas of the proliferation. In other types of Hodgkin's disease, L26 positive cells occurred in small or large aggregates and generally represented a minor proportion of the population of lymphoid cells. These studies further support a B cell derivation for L & H variants of Reed-Sternberg cells and provide additional evidence that nodular lymphocyte predominance type Hodgkin's disease may represent a distinct entity, possibly an unusual low grade B cell lymphoma. These data also suggest that some Reed-Sternberg cells and variants present in other histologic types of Hodgkin's disease may be of B cell derivation, and precludes the use of L26 as a diagnostic discriminant in cases in which the distinction between Hodgkin's disease and non-Hodgkin's lymphoma is unclear.

Full text

PDF
211

Images in this article

213Figure 1
on p.213
214Figure 2
on p.214
215Figure 3
on p.215

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdulaziz Z., Mason D. Y., Stein H., Gatter K. C., Nash J. R. An immunohistological study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel. Histopathology. 1984 Jan;8(1):1–25. doi: 10.1111/j.1365-2559.1984.tb02318.x. [DOI] [PubMed] [Google Scholar]
  2. Burns B. F., Colby T. V., Dorfman R. F. Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers. Am J Surg Pathol. 1984 Apr;8(4):253–261. doi: 10.1097/00000478-198404000-00002. [DOI] [PubMed] [Google Scholar]
  3. Cartun R. W., Coles F. B., Pastuszak W. T. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues. Am J Pathol. 1987 Dec;129(3):415–421. [PMC free article] [PubMed] [Google Scholar]
  4. Dorfman R. F., Gatter K. C., Pulford K. A., Mason D. Y. An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease. Am J Pathol. 1986 Jun;123(3):508–519. [PMC free article] [PubMed] [Google Scholar]
  5. Griesser H., Feller A., Lennert K., Minden M., Mak T. W. Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders. J Clin Invest. 1986 Nov;78(5):1179–1184. doi: 10.1172/JCI112700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hansmann M. L., Gödde-Salz E., Hui P. K., Müller-Hermelink H. K., Lennert K. Cytogenetic findings in nodular paragranuloma (Hodgkin's disease with lymphocytic predominance; nodular) and in progressively transformed germinal centers. Cancer Genet Cytogenet. 1986 Apr 15;21(4):319–325. doi: 10.1016/0165-4608(86)90212-8. [DOI] [PubMed] [Google Scholar]
  7. Hansmann M. L., Zwingers T., Böske A., Löffler H., Lennert K. Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular). J Cancer Res Clin Oncol. 1984;108(3):321–330. doi: 10.1007/BF00390466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hsu S. M., Jaffe E. S. Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease. Am J Clin Pathol. 1984 Jul;82(1):29–32. doi: 10.1093/ajcp/82.1.29. [DOI] [PubMed] [Google Scholar]
  9. Kadin M. E., Muramoto L., Said J. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease. Am J Pathol. 1988 Feb;130(2):345–353. [PMC free article] [PubMed] [Google Scholar]
  10. Kadin M. E., Stites D. P., Levy R., Warnke R. Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin's disease. N Engl J Med. 1978 Nov 30;299(22):1208–1214. doi: 10.1056/NEJM197811302992203. [DOI] [PubMed] [Google Scholar]
  11. Knowles D. M., 2nd, Neri A., Pelicci P. G., Burke J. S., Wu A., Winberg C. D., Sheibani K., Dalla-Favera R. Immunoglobulin and T-cell receptor beta-chain gene rearrangement analysis of Hodgkin's disease: implications for lineage determination and differential diagnosis. Proc Natl Acad Sci U S A. 1986 Oct;83(20):7942–7946. doi: 10.1073/pnas.83.20.7942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Linder J., Ye Y., Armitage J. O., Weisenburger D. D. Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue. Mod Pathol. 1988 Jan;1(1):29–34. [PubMed] [Google Scholar]
  13. Lukes R. J., Butler J. J. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1063–1083. [PubMed] [Google Scholar]
  14. Miettinen M., Franssila K. O., Saxén E. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas. Cancer. 1983 Jun 15;51(12):2293–2300. doi: 10.1002/1097-0142(19830615)51:12<2293::aid-cncr2820511221>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  15. Norton A. J., Isaacson P. G. Monoclonal antibody L26: an antibody that is reactive with normal and neoplastic B lymphocytes in routinely fixed and paraffin wax embedded tissues. J Clin Pathol. 1987 Dec;40(12):1405–1412. doi: 10.1136/jcp.40.12.1405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pinkus G. S., Thomas P., Said J. W. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Am J Pathol. 1985 May;119(2):244–252. [PMC free article] [PubMed] [Google Scholar]
  17. Poppema S., Kaiserling E., Lennert K. Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres--a cytohistological study. Histopathology. 1979 Jul;3(4):295–308. doi: 10.1111/j.1365-2559.1979.tb03011.x. [DOI] [PubMed] [Google Scholar]
  18. Poppema S., Kaiserling E., Lennert K. Nodular paragranuloma and progressively transformed germinal centers. Ultrastructural and immunohistologic findings. Virchows Arch B Cell Pathol Incl Mol Pathol. 1979;31(3):211–225. doi: 10.1007/BF02889938. [DOI] [PubMed] [Google Scholar]
  19. Poppema S. The diversity of the immunohistological staining pattern of Sternberg-Reed cells. J Histochem Cytochem. 1980 Aug;28(8):788–791. doi: 10.1177/28.8.6777426. [DOI] [PubMed] [Google Scholar]
  20. Regula D. P., Jr, Hoppe R. T., Weiss L. M. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N Engl J Med. 1988 Jan 28;318(4):214–219. doi: 10.1056/NEJM198801283180404. [DOI] [PubMed] [Google Scholar]
  21. Stein H., Gerdes J., Lemke H., Mason D. Y. Evidence of Sternberg-Reed cells being derived from activated lymphocytes. Haematol Blood Transfus. 1985;29:441–444. doi: 10.1007/978-3-642-70385-0_91. [DOI] [PubMed] [Google Scholar]
  22. Stein H., Hansmann M. L., Lennert K., Brandtzaeg P., Gatter K. C., Mason D. Y. Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Am J Clin Pathol. 1986 Sep;86(3):292–297. doi: 10.1093/ajcp/86.3.292. [DOI] [PubMed] [Google Scholar]
  23. Timens W., Visser L., Poppema S. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. Lab Invest. 1986 Apr;54(4):457–461. [PubMed] [Google Scholar]
  24. Warnke R. A., Gatter K. C., Falini B., Hildreth P., Woolston R. E., Pulford K., Cordell J. L., Cohen B., De Wolf-Peeters C., Mason D. Y. Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med. 1983 Nov 24;309(21):1275–1281. doi: 10.1056/NEJM198311243092102. [DOI] [PubMed] [Google Scholar]
  25. Weiss L. M., Strickler J. G., Hu E., Warnke R. A., Sklar J. Immunoglobulin gene rearrangements in Hodgkin's disease. Hum Pathol. 1986 Oct;17(10):1009–1014. doi: 10.1016/s0046-8177(86)80084-3. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES